Glucocorticoid use in acute lymphoblastic leukaemia
Glucocorticoid use in acute lymphoblastic leukaemia
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Glucocorticoids (prednisone and dexamethasone) play an essential part in the treatment of acute lymphoblastic leukaemia (ALL), but their optimum doses and bioequivalence have not been established. Results of preclinical studies have shown that dexamethasone has a longer half-life and better CNS penetration than does prednisone. In prospecti...
Alternative Titles
Full title
Glucocorticoid use in acute lymphoblastic leukaemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_762451125
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_762451125
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(10)70114-5
